{"id":5334,"date":"2021-02-01T07:44:17","date_gmt":"2021-02-01T06:44:17","guid":{"rendered":"http:\/\/source.wpopal.com\/editech\/about-us\/"},"modified":"2025-10-03T12:12:10","modified_gmt":"2025-10-03T10:12:10","slug":"aboutus","status":"publish","type":"page","link":"https:\/\/www.safilens.com\/en\/our-mission\/aboutus\/","title":{"rendered":"About Us"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

The passion for doing well<\/h2>About Safilens<\/span><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Safilens was founded in 2001 with the aim of creating innovative and high quality products in the contact lens sector. A solid company that has made use of the experience of its founders to provide solutions that are always in line with the evolution of the market and the needs of contact lens wearers.<\/p>

The true value of the company is the excellence of its Research & Development department and the attention and dedication of the Customer Care.<\/p>

Since 2012 Safilens is part of Bruno Farmaceutici, an Italian pharma company, founded in Rome in 1996 and leader in Italy in the oral cortisone and anti-diabetic sector. The acquisition by Bruno Farmaceutici has made available the wealth of scientific skills and the value of pharmaceutical know-how and development.<\/p>

The achieved results demonstrate the importance and efficiency of this synergy: high-performance products, immediate responses to customer needs, technological leadership in the sector.<\/p>

Safilens, thanks to a modern and independent approach, continues to develop products and technologies that focus on the well-being of the user. <\/p><\/div>\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Partners opinion<\/h2><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n
\n
\n
\n
\"\"<\/figure><\/div>
\n

Fabian Hasert<\/h3>
\n

Managing Director | MPG&E Handel und Service GmbH (DEU)<\/strong><\/p>

\"Safilens is one of the most innovative contact lens companies in Europe

We have been working with our Italian business partner Safilens here on the German market for five years now. Over the past five years, the scope of our business cooperation has grown steadily. We are very happy about this in human and business terms.

With Safilens, we have a professional and reliable contact lens manufacturer as a partner who has outstanding innovative strength that we will not want to do without in the future either\"<\/p> <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\"\"<\/figure><\/div>
\n

Rob Oorthuizen<\/h3>
\n

General Manager | Ot\u00e9 (NED)<\/strong><\/p>

\u201cBoth companies\u2019 vast range of high-quality products, utmost flexibility and Safilens\u2019 exemplary service record with Italian opticians are the ingredients for the ideal business model and I am certain they will lead us to major milestones\u201d<\/p> <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\"\"<\/figure><\/div>
\n

Jonas Frangenheim<\/h3>
\n

General Manager | Conil AG (SUI)<\/strong><\/p>

\"We have been working successfully with Safilens for many years and have a reliable partner \/ supplier with them.<\/p>

The innovative products offer added value in our portfolio, but above all added value for opticians in Switzerland\"<\/p> <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\"\"<\/figure><\/div>
\n

Robert Ruiner<\/h3>
\n

CEO & Founder | Ottiko GmbH (AUT)<\/p>

We have been Safilens'exclusive distributor for Austria for 8 years and both our customers and ourselves are thrilled with the unique quality and innovative products of Safilens.<\/p>

We're proud of being part of this success story\"<\/p> <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Our milestones<\/h2>TIMELINE<\/span><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\n
\n
\n \n
\n\n
\n
\n \"safilo\"\n <\/div>\n <\/div>\n \n \n
\n
\n
2001<\/div>\n \n

Date of establishment<\/h2>\n \n \n \n <\/div>\n <\/div>\n\n <\/div>\n \n
\n\n
\n
\n \"safilopartner\"\n <\/div>\n <\/div>\n \n \n
\n
\n
2001-2004<\/div>\n \n

Partnership with Safilo<\/h2>\n \n
\n

Fashion brands in CL industry<\/p> <\/div>\n \n \n <\/div>\n <\/div>\n\n <\/div>\n \n

\n\n
\n
\n \"310cXi+buHL._AC_\"\n <\/div>\n <\/div>\n \n \n
\n
\n
2005<\/div>\n \n

Controlled release technology<\/h2>\n \n
\n

Worlds first contact lenses with Hyaluronic Acid - Hydromade Technology<\/p> <\/div>\n \n \n <\/div>\n <\/div>\n\n <\/div>\n \n

\n\n
\n
\n \"7days\"\n <\/div>\n <\/div>\n \n \n
\n
\n
2007<\/div>\n \n

Multipurpose solutions with Hyaluronic Acid<\/h2>\n \n
\n

Weekly replacement Safe-Gel 7days are launched and the production of LC solutions starts<\/p> <\/div>\n \n \n <\/div>\n <\/div>\n\n <\/div>\n \n

\n\n
\n
\n \"fusiontechnology\"\n <\/div>\n <\/div>\n \n \n
\n
\n
2011<\/div>\n \n

Fusiontechnology<\/h2>\n \n
\n

The synergistic actions of Hyaluronic Acid and\nTSP\u00ae for a long-lasting natural comfort<\/p> <\/div>\n \n \n <\/div>\n <\/div>\n\n <\/div>\n \n

\n\n
\n
\n \"bruno\"\n <\/div>\n <\/div>\n \n \n
\n
\n
2012<\/div>\n \n

Bruno Farmaceutici<\/h2>\n \n
\n

Safilens is aquired by Bruno Farmaceutici group<\/p> <\/div>\n \n

\n \n Info <\/a>\n <\/div>\n\n \n <\/div>\n <\/div>\n\n <\/div>\n \n
\n\n
\n
\n \"progetto-open\"\n <\/div>\n <\/div>\n \n \n
\n
\n
2013<\/div>\n \n

The Open project<\/h2>\n \n
\n

The joint development of a material, a contact lens, a multipurpose solution and a sonication device to reduce CL side effects<\/p> <\/div>\n \n \n <\/div>\n <\/div>\n\n <\/div>\n \n

\n\n
\n
\n \"afocale\"\n <\/div>\n <\/div>\n \n \n
\n
\n
2015<\/div>\n \n

EDOF Afocal design<\/h2>\n \n
\n

An absolute novelty for the industry. The patented afocal design with enhanced depth of focus for the compensation of presbyopia<\/p> <\/div>\n \n \n <\/div>\n <\/div>\n\n <\/div>\n \n

\n\n
\n
\n \"FU1FTL30\"\n <\/div>\n <\/div>\n \n \n
\n
\n
2016<\/div>\n \n

Sleekform Toric Design<\/h2>\n \n
\n

The new pure-prism geometry for astigmatism, the thinnest in the industry<\/p> <\/div>\n \n \n <\/div>\n <\/div>\n\n <\/div>\n \n

\n\n
\n
\n \"FU1FVL30\"\n <\/div>\n <\/div>\n \n \n
\n
\n
2017<\/div>\n \n

D-stress design<\/h2>\n \n
\n

The EDOF Afocal design declined in an accomodative effort saving daily disposable for digital devices.
Fusion 1day family is now available in 4 segments<\/p> <\/div>\n \n \n <\/div>\n <\/div>\n\n <\/div>\n \n

\n\n
\n
\n \"DY1DTL30\"\n <\/div>\n <\/div>\n \n \n
\n
\n
2021<\/div>\n \n

Delivery Tyro<\/h2>\n \n
\n

The new Lachryceutical relasing family of daily disposables. Controlled relase of the amno-acid Tyrosine for the ocular development<\/p> <\/div>\n \n \n <\/div>\n <\/div>\n\n <\/div>\n \n

\n\n
\n
\n \"DR-05\"\n <\/div>\n <\/div>\n \n \n
\n
\n
2025<\/div>\n \n

Delivery Ribo<\/h2>\n \n
\n

Contect lenses releasing Riboflavin for the modern wearer lifestyle<\/p> <\/div>\n \n \n <\/div>\n <\/div>\n\n <\/div>\n <\/div>\n <\/div>\n\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n
<\/div>\n <\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\n
\n
<\/div>\n
<\/div>\n <\/div>\n
\n\n \n \n \n

\n Bruno Farmaceutici <\/h2>\n \n
\n Bruno Farmaceutici was founded in 1996, when Dr. Antonio Bruno decided to aquire Lepetit from pharma multinational Aventis.<\/br>\n\nQuesto progetto, peraltro, \u00e8 stato condiviso da un gruppo di Farmacisti, Chimici, Biologi e Medici, uniti da una sola motivazione etica: la passione di immaginare e di realizzare farmaci.<\/br>\n\nOver the years, the company,believing in its potential, has embarked on a development path in various therapeutic areas, reaching a significant increase in its product portfolio over time.<\/br>\n\nThe acquisition of Safilens in 2012 is part of the diversification and internationalization process implemented by the group.<\/br>\n\nThis operation allows, on the one hand, the expansion of the company in a market with a great future prospect such as that of contactology and, on the other hand, makes available to Safilens the wealth of scientific skills and all the value of pharmaceutical research and development of Bruno. <\/div>\n \n
\n \n \n <\/i>\n <\/span>\n Vai al sito Bruno Farmaceutici<\/span>\n <\/a>\n <\/div>\n <\/div>\n <\/div>\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Certificazioni & Responsabilit\u00e0 Sociale<\/h2>Safilens has always been committed to maintaining the highest quality standards, for the benefit of its customers, suppliers, employees and notified bodies globally<\/span><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t\t
Quality Management System<\/div>\n\t\t\t\t\t\t\t\t\t
EC Certificate Contact Lenses<\/div>\n\t\t\t\t\t\t\t\t\t
EC Certificate Lens Care<\/div>\n\t\t\t\t\t\t\t\t\t
Social Responsibility<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t
\n\t\t\t\t\t\t\t\t\t
Quality Management System<\/div>\n\t\t\t\t\t